X-linked Retinoschisis clinical trials at University of California Health

• Safety and Efficacy of rAAV-hRS1 in Patients With X-linked Retinoschisis (XLRS)

  Sorry, in progress, not accepting new patients

  This study will evaluate the safety and efficacy of a recombinant adeno-associated virus vector expressing retinoschisin (rAAV2tYF-CB-hRS1) in patients with X-linked retinoschisis. Up to 27 participants will be enrolled and 3 dose levels will be evaluated in a dose escalation format.

  at UCSF

Last updated: July 2020